Officers, Directors and Employees. Prior to the date hereof, the Company has provided to Parent a list that completely and accurately sets forth the name and current annual salary rate of each officer or exempt employee of the Company or any Subsidiary whose total remuneration for the last fiscal year was, or for the current fiscal year has been set at, in excess of $50,000, together with a summary of the bonuses, commissions and additional compensation, if any, paid or payable to such persons for the last fiscal year and proposed for the current fiscal year. The Disclosure Schedule completely and accurately sets forth (i) the names of all former employees whose employment with the Company or any Subsidiary has terminated either voluntarily or involuntarily during the preceding 12-month period; and (ii) the names of the officers (with all positions and titles indicated) and directors of the Company and each Subsidiary. No unfair labor practice complaint against the Company or any Subsidiary is pending before the National Labor Relations Board, and there is no labor strike, slowdown or stoppage pending or, to the knowledge of the Company, threatened against or involving the Company or any Subsidiary. Since January 1, 1995, no unionizing efforts have, to the knowledge of the Company, been made by employees of the Company or any Subsidiary, neither the Company nor any Subsidiary is a party to or subject to any collective bargaining agreement, and no collective bargaining agreement is currently being negotiated by the Company or any Subsidiary. There is no material labor dispute pending or, to the knowledge of the Company, threatened between the Company or any Subsidiary and its employees.
Appears in 2 contracts
Samples: Merger Agreement (Medtronic Inc), Merger Agreement (Avecor Cardiovascular Inc)
Officers, Directors and Employees. Prior to the date hereof, the Company has provided to Parent a list that completely and accurately sets forth the name and current annual salary rate of each executive officer or exempt employee of the Company or of any Subsidiary whose total remuneration for the last fiscal year was, or for the current fiscal year has been set atis expected to be, in excess of $50,000100,000, together with a summary of the bonuses, commissions and commissions, additional compensation, and other like cash benefits, if any, paid or payable to such persons for the last fiscal year and proposed for the current fiscal year. The Company Disclosure Schedule completely and accurately sets forth (i) the names of all former employees executive officers of the Company or of any Subsidiary whose employment with the Company or any Subsidiary has terminated either voluntarily or involuntarily during the preceding 12-month period; and (ii) the names of the executive officers (with all positions and titles indicated) and directors of the Company and of each Subsidiary. No Except as would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect: (i) no unfair labor practice complaint against the Company or any Subsidiary is pending before the National Labor Relations Board, and there is no labor strike, slowdown or stoppage pending or, to the knowledge of the Company, threatened in writing against or involving the Company or any Subsidiary. Since January 1, 1995, ; (ii) no unionizing efforts have, to the knowledge of the Company, been made by employees of the Company or any Subsidiary, neither the Company nor any Subsidiary is a party to or subject to any collective bargaining agreement, and no collective bargaining agreement is currently being negotiated by the Company or any Subsidiary. There ; and (iii) there is no material labor dispute pending or, to the knowledge of the Company, threatened in writing between the Company or any Subsidiary and its employees.
Appears in 2 contracts
Samples: Merger Agreement (Medtronic Inc), Merger Agreement (Xomed Surgical Products Inc)
Officers, Directors and Employees. Prior to the date hereof, the Company has provided to Parent a list that completely and accurately sets forth the name and current annual salary rate of each officer or exempt employee of the Company or any Subsidiary whose total remuneration for the last fiscal year was, or for the current fiscal year has been set at, in excess of $50,000150,000, together with a summary of the bonuses, commissions and commissions, additional compensation, and other like cash benefits, if any, paid or payable to such persons for the last fiscal year and proposed for the current fiscal year. The Company Disclosure Schedule completely and accurately sets forth (i) the names of all former employees officers of the Company whose employment with the Company or any Subsidiary has terminated either voluntarily or involuntarily during the preceding 12-month period; and (ii) the names of the officers (with all positions and titles indicated) and directors of the Company. Except as could not reasonably by expected to have a Company and each Subsidiary. No Material Adverse Effect: (i) no unfair labor practice complaint against the Company or any Subsidiary is pending before the National Labor Relations Board, and there is no labor strike, slowdown or stoppage pending or, to the knowledge of the Company, threatened in writing against or involving the Company or any Subsidiary. Since January 1, 1995, ; (ii) no unionizing efforts have, to the knowledge of the Company, been made by employees of the Company or any Subsidiary, neither the Company nor any Subsidiary is a party to or subject to any collective bargaining agreement, and no collective bargaining agreement is currently being negotiated by the Company or any Subsidiary. There ; and (iii) there is no material labor dispute pending or, to the knowledge of the Company, threatened in writing between the Company or any Subsidiary and its employees.
Appears in 2 contracts
Samples: Merger Agreement (Sofamor Danek Group Inc), Merger Agreement (Medtronic Inc)